Concurrent PRMT5 and TCL1 expression resulted in a more rapid disease onset with increased lymph node involvement and overt lymphomagenesis that appeared to recapitulate disease behavior seen in human RT, representing a model to mimic large B-cell lymphomas that arise from CLL. This evidence concerns the gene PRMT5 and B-cell non-Hodgkin lymphoma.